EMT and MET: necessary or permissive for metastasis?
M. K. Jolly, K. E. Ware, S. Gilja, J. A. Somarelli, H. Levine
Abstract
Epithelial-to-mesenchymal transition (EMT) and its reverse mesenchymal-to-epithelial transition (MET) have been often suggested to play crucial roles in metastatic dissemination of carcinomas. Recent studies have revealed that neither of these processes is binary. Instead, carcinoma cells often exhibit a spectrum of epithelial/mesenchymal phenotype(s). While epithelial-mesenchymal plasticity has been observed pre-clinically and clinically, whether any of these phenotypic transitions are indispensable for metastatic outgrowth remains an unanswered question. Here, we focus on epithelial-mesenchymal plasticity in metastatic dissemination and propose alternative mechanisms for successful dissemination and metastases beyond the traditional EMT-MET view. We highlight multiple hypotheses that can help reconcile conflicting observations, and outline the next set of key questions that can offer valuable insights into mechanisms of metastasis in multiple tumor models.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Plausible Accelerating Function of Intermediate States in Cancer Metastasis
Hanah Goetz, Juan Ramon Melendez-Alvarez, … Xiao‐Jun Tian·PLoS Computational BiologyPeer-reviewed·Mar 10, 2020
- Multiple distinct metastatic cell states are induced by epithelial-mesenchymal plasticity
Fahda Alsharief, Robert K. Suter, … Gray W. Pearson·bioRxiv·Aug 15, 2025
- A mathematical multi-organ model for bidirectional epithelial-mesenchymal transitions in the metastatic spread of cancer
L. C. Franssen, M. A. Chaplain·bioRxiv·Aug 28, 2019
- Understanding and leveraging phenotypic plasticity during metastasis formation
S. Shah, L.-M. Philipp, … M. Raatz·bioRxiv·Nov 7, 2022
- Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer
L. Eichelberger, M. Saini, … C. H. Scheel·bioRxiv·Mar 19, 2020
- Dynamic plasticity within the EMT spectrum, rather than static mesenchymal traits, drives tumor heterogeneity and metastatic progression of breast cancers
M. S. Brown, B. Abdollahi, … D. R. Pattabiraman·bioRxiv·Mar 17, 2021